GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (NAS:FBLG) » Definitions » Total Long-Term Assets

FibroBiologics (FibroBiologics) Total Long-Term Assets : $2.48 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. FibroBiologics's Total Long-Term Assets for the quarter that ended in Mar. 2024 was $2.48 Mil.


FibroBiologics Total Long-Term Assets Historical Data

The historical data trend for FibroBiologics's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Total Long-Term Assets Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23
Total Long-Term Assets
- 2.20 2.61

FibroBiologics Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only - 2.08 2.39 2.61 2.48

FibroBiologics Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.


FibroBiologics Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of FibroBiologics's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


FibroBiologics (FibroBiologics) Business Description

Comparable Companies
Traded in Other Exchanges
Address
455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
FibroBiologics Inc is an early-stage, cell therapy company. Its primary focus is the initiation and progression of preclinical studies and clinical-stage FDA trials related to fibroblast treatments for Degenerative Disc Disease, Multiple Sclerosis, Cancer, Wound Healing, and other diseases.

FibroBiologics (FibroBiologics) Headlines